Holding a joint meeting of, Darman Ara and Badr Tajhiz Iranian companies
According to the report of Public Relations and International Affairs of Council for Development of Stem Cell Science and Technoloies, the meeting was held in the presence of Dr. Hamidieh, Secretary of council, Dr. Sadri, CEO of Darman Ara Company and Dr. Mahdavian, CEO of Badr Tajhiz Iranian Company on Monday, 22 November 2021.
At first, Dr. Sadri introduced the Ara Treatment Company. This company started its activity in 1999 by registering and importing the products of Biotest and B. Brown companies and the founder of the first private plasmapheresis centers in 2004 through joint cooperation with Biotest Company to collect, contract production and import plasma derivative products. These include: Immunoglobulins, blood coagulation factors and albumin to Iran.
The newly established Badr Tajhiz Iranian Company, with the support of Council for Development of Stem Cell Science and Technoloies, has recently succeeded in making a prototype of a plasmapheresis equipment. With the aim of manufacturing and commercializing the equipment needed in the field of stem cells and regenerative medicine, this Council connects start-up knowledge-based companies to related investors and provides the base for their cooperation.
ارسال به دوستان